Your browser doesn't support javascript.
loading
Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy.
Chan, Jean L; Koda, Joy; Heilig, Joseph S; Cochran, Elaine K; Gorden, Phillip; Oral, Elif A; Brown, Rebecca J.
Afiliación
  • Chan JL; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Koda J; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Heilig JS; AstraZeneca, San Diego, CA, USA.
  • Cochran EK; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Gorden P; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Oral EA; Division of Metabolism, Endocrinology & Diabetes (MEND), University of Michigan, Ann Arbor, MI, USA.
  • Brown RJ; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Clin Endocrinol (Oxf) ; 85(1): 137-49, 2016 07.
Article en En | MEDLINE | ID: mdl-26589105

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leptina / Lipodistrofia / Obesidad Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Endocrinol (Oxf) Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leptina / Lipodistrofia / Obesidad Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Endocrinol (Oxf) Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos
...